Skip to main content
. 2019 Apr 15;11(4):2081–2089.

Figure 6.

Figure 6

Exenatide ameliorated advanced glycation end products (AGEs)-induced degradation of aggrecan in human primary chondrocytes. Human primary chondrocytes were stimulated with 100 μg/ml AGEs in the presence or absence of exendin-4 (a form of exenatide) at the concentrations of 10 and 20 nM for 48 h. Expression of aggrecan was determined (a, b, c, P < 0.01 vs. previous column group).